(ARWR) Arrowhead Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Arrowhead Pharmaceuticals | (ARWR) share price targets
Complete technical analysis of Arrowhead Pharmaceuticals (ARWR) by charts plus indicators, forecast predictions and share price targets for Arrowhead Pharmaceuticals (ARWR)
Arrowhead Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-01 View latest technical analysis
10 day averaged volume of Arrowhead Pharmaceuticals is 759250
Date | Daily Closing Price | Open | High | Low | Volume |
01 Fri Nov 2024 | 19.49 | 19.55 | 19.85 | 19.30 | 1.388 times |
31 Thu Oct 2024 | 19.23 | 19.55 | 19.67 | 19.20 | 0.826 times |
30 Wed Oct 2024 | 19.71 | 19.80 | 20.10 | 19.50 | 1.069 times |
29 Tue Oct 2024 | 19.98 | 19.92 | 20.43 | 19.68 | 0.765 times |
28 Mon Oct 2024 | 20.18 | 20.47 | 20.87 | 20.10 | 1.12 times |
25 Fri Oct 2024 | 20.10 | 20.00 | 20.63 | 19.82 | 0.856 times |
24 Thu Oct 2024 | 19.93 | 20.02 | 20.36 | 19.71 | 0.858 times |
23 Wed Oct 2024 | 19.92 | 20.26 | 20.43 | 19.68 | 0.81 times |
22 Tue Oct 2024 | 20.38 | 20.46 | 20.50 | 20.02 | 0.738 times |
21 Mon Oct 2024 | 20.49 | 21.09 | 21.17 | 19.81 | 1.59 times |
My analysis of stock is bearish for shortterm, and stock might move down till 18.6 or till 17.3. Use a stoploss of 19.6 and if the stock hits stoploss, then it can shoot up till 20.64
Share price targets for Arrowhead Pharmaceuticals (ARWR)
Target Type | Value |
Downside Target | 17.05 |
Downside Target | 18.15 |
Downside Target | 18.89 |
Upside Target | 20.87 |
Upside Target | 21.17 |
Upside Target | 21.44 |
Upside Target | 22.11 |
Upside Target | 24.57 |
Upside Target | 24.77 |
Upside Target | 28.72 |
Upside Target | 30.41 |
Intraday share price targets for Arrowhead Pharmaceuticals (ARWR)
Target Type | Value |
Downside Intraday Target | 18.84 |
Downside Intraday Target | 18.18 |
Upside Intraday Target | 20.51 |
Upside Intraday Target | 21.52 |
Upside Intraday Target | 19.85 |
Weekly technical analysis of Arrowhead Pharmaceuticals (ARWR)
Date | Weekly Closing Price | Open | High | Low | Volume |
01 Fri Nov 2024 | 19.49 | 20.47 | 20.87 | 19.20 | 1.065 times |
25 Fri Oct 2024 | 20.10 | 21.09 | 21.17 | 19.68 | 0.587 times |
18 Fri Oct 2024 | 21.18 | 18.50 | 21.44 | 18.40 | 1.113 times |
11 Fri Oct 2024 | 18.44 | 18.74 | 18.89 | 17.05 | 1.027 times |
04 Fri Oct 2024 | 18.82 | 19.33 | 19.76 | 18.15 | 1.193 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arrowhead Pharmaceuticals (ARWR)
Date | Monthly Closing Price | Open | High | Low | Volume |
01 Fri Nov 2024 | 19.49 | 19.55 | 19.85 | 19.30 | 0.048 times |
31 Thu Oct 2024 | 19.23 | 19.20 | 21.44 | 17.05 | 0.941 times |
30 Mon Sep 2024 | 19.37 | 24.02 | 24.77 | 19.07 | 1.039 times |
30 Fri Aug 2024 | 23.83 | 28.46 | 28.72 | 22.11 | 1.161 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arrowhead Pharmaceuticals (ARWR)
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arrowhead Pharmaceuticals in short term but the buy signal is initial and weak.
Arrowhead Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arrowhead Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 19.96 and Arrowhead Pharmaceuticals (ARWR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals (ARWR) stock. Volume based technical analysis of Arrowhead Pharmaceuticals (ARWR) stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arrowhead Pharmaceuticals ( (ARWR) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arrowhead Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arrowhead Pharmaceuticals in short term but the buy signal is initial and weak.
Arrowhead Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arrowhead Pharmaceuticals in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arrowhead Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 19.96 and Arrowhead Pharmaceuticals (ARWR) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arrowhead Pharmaceuticals (ARWR) stock. Volume based technical analysis of Arrowhead Pharmaceuticals (ARWR) stock is negative.
Arrowhead Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.